Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Operating Officer

Chief Business Officer

Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious and autoimmunity diseases, and cancers. The company's therapeutic programs include VTP-300, which is in Phase 2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1b/2 clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.

Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-06-26	Premium	bought	Premium	Premium	Premium	-
2023-05-25	Premium	bought	Premium	Premium	Premium	-
2023-03-27	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-09-30	Premium	sold	Premium	Premium	Premium	-
2022-09-30	Premium	acquired	Premium	Premium	Premium	-
2022-08-25	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-08-25	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-08-25	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2022-08-24	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-08-24	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-08-18	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-08-18	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-08-17	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-08-17	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-08-17	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2022-08-16	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-08-16	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2022-08-16	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-08-15	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2022-08-15	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-08-15	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-08-12	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2022-06-28	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-06-28	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-06-24	Premium	acquired	Premium	Premium	Premium	Chief Business Officer

VACC - Vaccitech plc Stock Price, Fair Value and News

Latest Insider Trading transactions for VACC